SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-025709
Filing Date
2022-05-12
Accepted
2022-05-12 07:42:29
Documents
54
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_gamidacell.htm   iXBRL 10-Q 1004538
2 CERTIFICATION f10q0322ex31-1_gamidacell.htm EX-31.1 9864
3 CERTIFICATION f10q0322ex31-2_gamidacell.htm EX-31.2 9877
4 CERTIFICATION f10q0322ex32-1_gamidacell.htm EX-32.1 3660
5 CERTIFICATION f10q0322ex32-2_gamidacell.htm EX-32.2 3622
  Complete submission text file 0001213900-22-025709.txt   3530482

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE gmda-20220331.xsd EX-101.SCH 34434
7 XBRL CALCULATION FILE gmda-20220331_cal.xml EX-101.CAL 23964
8 XBRL DEFINITION FILE gmda-20220331_def.xml EX-101.DEF 148722
9 XBRL LABEL FILE gmda-20220331_lab.xml EX-101.LAB 319557
10 XBRL PRESENTATION FILE gmda-20220331_pre.xml EX-101.PRE 161237
48 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_gamidacell_htm.xml XML 244385
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38716 | Film No.: 22915749
SIC: 2836 Biological Products, (No Diagnostic Substances)